Business ❯ Mergers and Acquisitions

Pharmaceutical Industry

Investment Drug Development Competition Biotechnology Perrigo Co Cancer Treatment Rare Disease Drugs Genetic Testing AI in Drug Development Obesity Drugs

Lilly in Advanced Talks to Buy Kelonia for More Than $2 Billion, Reports Say

The potential purchase would extend Lilly’s push beyond weight-loss drugs into cancer treatments.

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Bristol Myers Squibb Buys Orbital Therapeutics for $1.5 Billion to Push In Vivo CAR‑T Into Autoimmune Care

Biontech, Curevac Agree on $740 Million Covid-19 Vaccine Patent Settlement

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Regeneron to Acquire 23andMe for $256 Million Following Bankruptcy Auction

Chemist Warehouse-Sigma Merger Approved, Creating $8.8 Billion Pharma Giant

Eli Lilly Acquires Morphic for $3.2 Billion

Merck to Acquire EyeBio for Up to $3 Billion

FDA Approves Revolutionary $4.25 Million Gene Therapy for Rare Genetic Disorder

AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal to Boost Cancer Treatment Pipeline

Roche to Acquire Carmot Therapeutics in $2.7 Billion Deal

AbbVie Acquires ImmunoGen for $10.1 Billion, Gaining Access to Promising Ovarian Cancer Drug